A citation-based method for searching scientific literature

Alexander Drilon, Salvatore Siena, Sai-Hong Ignatius Ou, Manish Patel, Myung Ju Ahn, Jeeyun Lee, Todd M Bauer, Anna F Farago, Jennifer J Wheler, Stephen V Liu, Robert Doebele, Laura Giannetta, Giulio Cerea, Giovanna Marrapese, Michele Schirru, Alessio Amatu, Katia Bencardino, Laura Palmeri, Andrea Sartore-Bianchi, Angelo Vanzulli, Sara Cresta, Silvia Damian, Matteo Duca, Elena Ardini, Gang Li, Jason Christiansen, Karey Kowalski, Ann D Johnson, Rupal Patel, David Luo, Edna Chow-Maneval, Zachary Hornby, Pratik S Multani, Alice T Shaw, Filippo G De Braud. Cancer Discov 2017
Times Cited: 448



Alison M Schram, Matthew T Chang, Philip Jonsson, Alexander Drilon. Nat Rev Clin Oncol 2017
Times Cited: 154




List of shared articles



Times cited

An insight into lung cancer: a comprehensive review exploring ALK TKI and mechanisms of resistance.
Adela Patcas, Ana Florica Chis, Claudia Florentina Militaru, Ioana Roxana Bordea, Ruxandra Rajnoveanu, Ovidiu Florin Coza, Reem Hanna, Tamas Tiberiu, Doina Adina Todea. Bosn J Basic Med Sci 2022
1

Mesenchymal neoplasms with NTRK and other kinase gene alterations.
Jessica L Davis, Alyaa Al-Ibraheemi, Erin R Rudzinski, Lea F Surrey. Histopathology 2022
0

ROS1-dependent cancers - biology, diagnostics and therapeutics.
Alexander Drilon, Chelsea Jenkins, Sudarshan Iyer, Adam Schoenfeld, Clare Keddy, Monika A Davare. Nat Rev Clin Oncol 2021
37

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors.
Emiliano Cocco, Ji Eun Lee, Srinivasaraghavan Kannan, Alison M Schram, Helen H Won, Sophie Shifman, Amanda Kulick, Laura Baldino, Eneda Toska, Amaia Arruabarrena-Aristorena,[...]. Cancer Discov 2021
16

Kinase gene fusions: roles and therapeutic value in progressive and refractory papillary thyroid cancer.
Mian Liu, Pei Chen, Hui-Yu Hu, Deng-Jie Ou-Yang, Rooh-Afza Khushbu, Hai-Long Tan, Peng Huang, Shi Chang. J Cancer Res Clin Oncol 2021
3

Assessment of the toxicity and toxicokinetics of the novel potent tropomyosin receptor kinase (Trk) inhibitor LPM4870108 in rhesus monkeys.
Sijin Duan, Lin Dong, Bingsi Wang, Shujuan Wei, Xiaoyan Gong, Pengfei Yu, Chunmei Li, Yonglin Gao, Liang Ye, Hongbo Wang,[...]. Regul Toxicol Pharmacol 2021
2

Fusion proteins in lung cancer: addressing diagnostic problems for deciding therapy.
Federica Zito Marino, Greta Alì, Francesco Facchinetti, Luisella Righi, Gabriella Fontanini, Giulio Rossi, Renato Franco. Expert Rev Anticancer Ther 2021
3

Precision oncology in metastatic colorectal cancer - from biology to medicine.
Federica Di Nicolantonio, Pietro Paolo Vitiello, Silvia Marsoni, Salvatore Siena, Josep Tabernero, Livio Trusolino, Rene Bernards, Alberto Bardelli. Nat Rev Clin Oncol 2021
24

Evolving role of entrectinib in treatment of NTRK-positive tumors.
Neal Chawla, Nam Q Bui, Mahesh Seetharam. Future Oncol 2021
0